NVision Medical
Device to collect cells from fallopian tubes used for early detection of ovarian cancer.
Launch date
Employees
Market cap
-
Enterprise valuation
$275m (Public information from Apr 2018)
San Bruno California (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
$250k | Seed | ||
$4.1m | Series A | ||
$12.0m | Series B | ||
* | $275m Valuation: $275m | Acquisition | |
| Total Funding | $16.4m | ||
Related Content
Recent News about NVision Medical
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.